Britain's medicine regulator on Thursday said there had been a further 41 reports of rare blood clots after doses of AstraZeneca's COVID-19 vaccine, but that the benefits of the shot continued to outweigh the risks for the majority of people. This will save lives, protect our community from unsafe variants and help us get out of this pandemic. We registered long back.
"As we follow the rapid spread of SARS-CoV-2 variants of concern, we believe that there will continue to be significant need for our mRNA COVID-19 vaccine and our variant booster candidates into 2022 and 2023".
To a question on the price of vaccines, Sudhakar said, "We have already announced that we will give the vaccine free of cost to everyone in the state. According to the guidance tool given to the states and the way we are handholding the states, we think that...this vaccination drive will start according to how we have designed it", he said.
Presenting real-world data on a subset of hospitalised COVID-19 patients in the United Kingdom, the researchers said the findings showed some level of "vaccine failure" - in other words cases where vaccinated people still become infected and get sick - but that this was "not unexpected".
"We're not done until the hardest-hit communities are vaccinated at the same rate as everyone else", said Dr. Rocio Luna, Santa Clara's deputy county executive and an East San Jose native.
Santa Clara County Supervisor Cindy Chavez urged parents to bring their teenagers of eligible age to get vaccinated.
Now from May 1, people above 18 years will be vaccinated.
Sudharshan Ballal, Chairman, Manipal Hospitals, told NDTV, "Vaccination is the key to breaking the chain of transmission for COVID-19".
He was reacting to the Government of India's direction to allow vaccinating people above 18 year from May 1.
"So depending upon. how much the ordering that happens is third doses or pediatric doses at 50 micrograms, we could see up to 3 billion doses", he added.
The announcements by the large chains notwithstanding, many private vaccination centres are not expected to receive doses of the vaccine from Saturday - many have, in fact, received communication from manufacturers that orders will be delayed for months.
Karnataka has been witnessing a sharp spike in cases over the past weeks and Bengaluru now has well over two lakh active cases - putting a huge strain on the health infrastructure. Bharat Biotech, a day after Serum, too has slashed the price of its Covaxin from Rs 600 to Rs 400 per dose for the state governments.